Selected research
Market Outlook & Growth Opportunities
Global Pet Obesity Management Market Outlook and Growth Opportunities 2026
Market perspective
The global Pet Obesity Management market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Pet Obesity Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pet Obesity Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pet Obesity Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Pet Obesity Management market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Pet Obesity Management market include Zoetis Inc (Pfizer), Novo Nordisk A/S, Vivaldis, Royal Canin, Pedigree Petfoods, Hill's Pet Nutrition, Inc and Auxthera LLC, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Pet Obesity Management market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pet Obesity Management and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pet Obesity Management revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pet Obesity Management market.
Pet Obesity Management Segment by Company
Zoetis Inc (Pfizer)
Novo Nordisk A/S
Vivaldis
Royal Canin
Pedigree Petfoods
Hill's Pet Nutrition, Inc
Auxthera LLC
Pet Obesity Management Segment by Type
Drugs
Food Supplements
Pet Obesity Management Segment by Application
Pet Specialty Stores
E-commerce
Others
Pet Obesity Management Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Pet Obesity Management status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Pet Obesity Management key companies, revenue, market share, and recent developments.
3. To split the Pet Obesity Management breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Pet Obesity Management market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Pet Obesity Management significant trends, drivers, influence factors in global and regions.
6. To analyze Pet Obesity Management competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Obesity Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pet Obesity Management and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Obesity Management.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pet Obesity Management industry.
Chapter 3: Detailed analysis of Pet Obesity Management company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Pet Obesity Management in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Pet Obesity Management in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Drugs
- Food Supplements
Applications
- Pet Specialty Stores
- E-commerce
- Others
Companies covered
- Zoetis Inc (Pfizer)
- Novo Nordisk A/S
- Vivaldis
- Royal Canin
- Pedigree Petfoods
- Hill's Pet Nutrition, Inc
- Auxthera LLC
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Pet Obesity Management Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Pet Obesity Management Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Pet Obesity Management Market Dynamics
- 2.1 Pet Obesity Management Industry Trends
- 2.2 Pet Obesity Management Industry Drivers
- 2.3 Pet Obesity Management Industry Opportunities and Challenges
- 2.4 Pet Obesity Management Industry Restraints
3 Pet Obesity Management Market by Company
- 3.1 Global Pet Obesity Management Company Revenue Ranking in 2025
- 3.2 Global Pet Obesity Management Revenue by Company (2021-2026)
- 3.3 Global Pet Obesity Management Company Ranking (2024-2026)
- 3.4 Global Pet Obesity Management Company Manufacturing Base and Headquarters
- 3.5 Global Pet Obesity Management Company Product Type and Application
- 3.6 Global Pet Obesity Management Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Pet Obesity Management Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Pet Obesity Management Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Pet Obesity Management Market by Type
- 4.1 Pet Obesity Management Type Introduction
- 4.1.1 Drugs
- 4.1.2 Food Supplements
- 4.2 Global Pet Obesity Management Sales Value by Type
- 4.2.1 Global Pet Obesity Management Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Pet Obesity Management Sales Value by Type (2021-2032)
- 4.2.3 Global Pet Obesity Management Sales Value Share by Type (2021-2032)
5 Pet Obesity Management Market by Application
- 5.1 Pet Obesity Management Application Introduction
- 5.1.1 Pet Specialty Stores
- 5.1.2 E-commerce
- 5.1.3 Others
- 5.2 Global Pet Obesity Management Sales Value by Application
- 5.2.1 Global Pet Obesity Management Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Pet Obesity Management Sales Value by Application (2021-2032)
- 5.2.3 Global Pet Obesity Management Sales Value Share by Application (2021-2032)
6 Pet Obesity Management Regional Value Analysis
- 6.1 Global Pet Obesity Management Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Pet Obesity Management Sales Value by Region (2021-2032)
- 6.2.1 Global Pet Obesity Management Sales Value by Region: 2021-2026
- 6.2.2 Global Pet Obesity Management Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Pet Obesity Management Sales Value (2021-2032)
- 6.3.2 North America Pet Obesity Management Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Pet Obesity Management Sales Value (2021-2032)
- 6.4.2 Europe Pet Obesity Management Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Pet Obesity Management Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Pet Obesity Management Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Pet Obesity Management Sales Value (2021-2032)
- 6.6.2 South America Pet Obesity Management Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Pet Obesity Management Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Pet Obesity Management Sales Value Share by Country, 2025 VS 2032
7 Pet Obesity Management Country-level Value Analysis
- 7.1 Global Pet Obesity Management Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Pet Obesity Management Sales Value by Country (2021-2032)
- 7.2.1 Global Pet Obesity Management Sales Value by Country (2021-2026)
- 7.2.2 Global Pet Obesity Management Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Pet Obesity Management Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Pet Obesity Management Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Pet Obesity Management Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Pet Obesity Management Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Pet Obesity Management Sales Value Growth Rate (2021-2032)
- 7.7.2 France Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Pet Obesity Management Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Pet Obesity Management Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Pet Obesity Management Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Pet Obesity Management Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Pet Obesity Management Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Pet Obesity Management Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Pet Obesity Management Sales Value Growth Rate (2021-2032)
- 7.14.2 China Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Pet Obesity Management Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Pet Obesity Management Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Pet Obesity Management Sales Value Growth Rate (2021-2032)
- 7.17.2 India Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Pet Obesity Management Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Pet Obesity Management Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Pet Obesity Management Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Pet Obesity Management Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Pet Obesity Management Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Pet Obesity Management Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Pet Obesity Management Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Pet Obesity Management Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Pet Obesity Management Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Pet Obesity Management Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Pet Obesity Management Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Pet Obesity Management Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Pet Obesity Management Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Pet Obesity Management Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Pet Obesity Management Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Zoetis Inc (Pfizer)
- 8.1.1 Zoetis Inc (Pfizer) Company Information
- 8.1.2 Zoetis Inc (Pfizer) Business Overview
- 8.1.3 Zoetis Inc (Pfizer) Pet Obesity Management Revenue and Gross Margin (2021-2026)
- 8.1.4 Zoetis Inc (Pfizer) Pet Obesity Management Product Portfolio
- 8.1.5 Zoetis Inc (Pfizer) Recent Developments
- 8.2 Novo Nordisk A/S
- 8.2.1 Novo Nordisk A/S Company Information
- 8.2.2 Novo Nordisk A/S Business Overview
- 8.2.3 Novo Nordisk A/S Pet Obesity Management Revenue and Gross Margin (2021-2026)
- 8.2.4 Novo Nordisk A/S Pet Obesity Management Product Portfolio
- 8.2.5 Novo Nordisk A/S Recent Developments
- 8.3 Vivaldis
- 8.3.1 Vivaldis Company Information
- 8.3.2 Vivaldis Business Overview
- 8.3.3 Vivaldis Pet Obesity Management Revenue and Gross Margin (2021-2026)
- 8.3.4 Vivaldis Pet Obesity Management Product Portfolio
- 8.3.5 Vivaldis Recent Developments
- 8.4 Royal Canin
- 8.4.1 Royal Canin Company Information
- 8.4.2 Royal Canin Business Overview
- 8.4.3 Royal Canin Pet Obesity Management Revenue and Gross Margin (2021-2026)
- 8.4.4 Royal Canin Pet Obesity Management Product Portfolio
- 8.4.5 Royal Canin Recent Developments
- 8.5 Pedigree Petfoods
- 8.5.1 Pedigree Petfoods Company Information
- 8.5.2 Pedigree Petfoods Business Overview
- 8.5.3 Pedigree Petfoods Pet Obesity Management Revenue and Gross Margin (2021-2026)
- 8.5.4 Pedigree Petfoods Pet Obesity Management Product Portfolio
- 8.5.5 Pedigree Petfoods Recent Developments
- 8.6 Hill's Pet Nutrition, Inc
- 8.6.1 Hill's Pet Nutrition, Inc Company Information
- 8.6.2 Hill's Pet Nutrition, Inc Business Overview
- 8.6.3 Hill's Pet Nutrition, Inc Pet Obesity Management Revenue and Gross Margin (2021-2026)
- 8.6.4 Hill's Pet Nutrition, Inc Pet Obesity Management Product Portfolio
- 8.6.5 Hill's Pet Nutrition, Inc Recent Developments
- 8.7 Auxthera LLC
- 8.7.1 Auxthera LLC Company Information
- 8.7.2 Auxthera LLC Business Overview
- 8.7.3 Auxthera LLC Pet Obesity Management Revenue and Gross Margin (2021-2026)
- 8.7.4 Auxthera LLC Pet Obesity Management Product Portfolio
- 8.7.5 Auxthera LLC Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst